MCP-1 induces hepatic steatosis and insulin resistance via up-regulating the expression of SREBP-1c, a transcription factor that regulates the expression of genes important in lipid synthesis, and glucose-6-phosphatase (G6Pase), an enzyme involved in hepatic glucose production (96). The gene discussed is CCL2; the disease is fatty liver disease.